000
| 02015cam 2200337zi 4500 |
---|
001 | 9.932246 |
---|
003 | CaOODSP |
---|
005 | 20240221155304 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 240109e202111##onc ob f000 0 eng d |
---|
020 | |a9780660695457 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP5-182/2024E-PDF |
---|
245 | 00|aEvidence brief on the risk of COVID-19 transmission in flight : |bupdate 3. |
---|
246 | 17|aCOVID-19 summary of flight transmission risk |
---|
264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cNovember 2021. |
---|
264 | 4|c©2021 |
---|
300 | |a1 online resource (51 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Synthèse en bref sur le risque de transmission du COVID-19 en vol : mise à jour 3. |
---|
504 | |aIncludes bibliographical references (pages 16-51). |
---|
520 | |a"Many changes have been implemented by airlines and national government during the pandemic to reduce the risk of SARS-CoV-2 transmission during air travel. This evidence brief summarizes the literature on in-flight transmission of SARS-CoV-2, the characteristics of these events, and the strategies implemented or proposed to mitigate transmission in an airplane or during boarding and disembarkation. This is the third update and includes studies up to November 25, 2021. The first and second update of this review contained literature published up to October 28, 2020 and April 26, 2021, respectively"--page 4. |
---|
650 | 0|aCOVID-19 (Disease)|xTransmission. |
---|
650 | 0|aFlight|xPhysiological aspects. |
---|
710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
---|
775 | 08|tSynthèse en bref sur le risque de transmission du COVID-19 en vol : |w(CaOODSP)9.932247 |
---|
856 | 40|qPDF|s1.61 MB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-182-2024-eng.pdf |
---|